Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 08:00 Hrs [IST] ...